GlassScriptPhysician profile
Jinen Shah
NPI 1629560032
$10,496.98
in general payments reported to CMS, 2019-2025
18 companies · $1,519 in 2025
The $1,519 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $201 · 2021: $209 · 2022: $739 · 2023: $1,998 · 2024: $5,154 · 2025: $1,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,466 · Travel and Lodging: $1,075 · Entertainment: $109 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,466.46 |
| Travel and Lodging | $1,075.17 |
| Entertainment | $109.00 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $3,751.17 | 2023-2024 | |
| Alcon Vision LLC | $2,367.50 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $993.33 | 2022-2025 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $886.39 | 2019-2025 | Acuvue |
| Coopervision INC. | $807.36 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Glaukos Corporation | $503.98 | 2024-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa, Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $208.25 | 2019-2021 | |
| Topcon Healthcare, INC. | $163.22 | 2024 | |
| Harrow Eye, LLC | $125.00 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $119.47 | 2023 | Cequa |
| Allergan, INC. | $117.86 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $117.72 | 2020 | |
| Optos, INC. | $109.00 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $90.94 | 2022 | |
| Rxsight INC | $76.26 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.90 | 2023 | Vuity |
| Tarsus Pharmaceuticals, INC. | $20.50 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $18.13 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinen Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.